tag:blogger.com,1999:blog-8358569997429791810.post6750906177933122853..comments2024-03-18T05:46:06.835-04:00Comments on HCV New Drugs: Natco moves to oppose Gilead hepatitis C drug patent in IndiaHCV New Drugshttp://www.blogger.com/profile/16049941177490552710noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-8358569997429791810.post-742027650293859732014-04-10T10:54:06.402-04:002014-04-10T10:54:06.402-04:00Mr RAJEEV NANNAPANENI if you have guts and courage...Mr RAJEEV NANNAPANENI if you have guts and courage then why don't you develop a new drug through research at your own pharma company (NATCO Pharma Ltd.). May be you are opposing this patent because you could not able to struck a deal with Gilead Sciences. If not able to do so then you have no right to oppose this patent application from Gilead and depriving people of India from the treatment.Fight against Hepatitis B and Chttps://www.blogger.com/profile/04329099270330085367noreply@blogger.comtag:blogger.com,1999:blog-8358569997429791810.post-25194399810303689662014-04-10T10:37:47.300-04:002014-04-10T10:37:47.300-04:00I Support Gilead patent in India because at least ...I Support Gilead patent in India because at least it is providing sofosbuvir at much cheaper rate as compared to the price in US. At least people who are covered through insurance may be able to get drug early. This plea against patent will delay the drug delivery to people who are in urgent need. Will Natco Chief Executive Rajeev Nannapaneni take resposibility for death of peoples who will be deprived from treatment due to unnecessary delay. Why people who are covered under insurance are deprived from treatment . Mr Rajeev Nannapaneni is only fighting for people who are not insured. It is the fault of non insured people who had not insured themselves.Fight against Hepatitis B and Chttps://www.blogger.com/profile/04329099270330085367noreply@blogger.com